Try our Advanced Search for more refined results
Illumina Inc. et al v. BGI Genomics Co., Ltd. et al
Case Number:
3:20-cv-01465
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 14, 2022
Illumina Pays Complete Genomics $325M To End DNA IP Row
After a Delaware federal jury determined Illumina willfully infringed DNA sequencing patents held by Complete Genomics Inc. and owes $334 million — a figure that could be tripled — CGI's Chinese parent MGI said Thursday its rival agreed to pay $325 million to resolve the parties' fights in California and the First State.
-
August 27, 2021
Complete Genomics Gets Trim Of Illumina's DNA Tech IP Suit
A California federal judge Friday trimmed Illumina's lawsuit purportedly seeking to stop Complete Genomics' "latest attempt at brazen infringement" of its DNA sequencing patents in a decade-long patent war, tossing a claim for literal infringement while declining to find a different Illumina patent invalid.
-
July 15, 2021
IP Forecast: Alsup To Hear Finjan's Fee Fight With Juniper
Finjan will argue next week it should not have to pay nearly $6 million in legal fees to Juniper Networks after losing a patent case that Judge William Alsup said was loaded with "patent B.S." Here's a look at where that case stands, plus the other major intellectual property matters on deck in the coming week.
-
May 27, 2021
IP Forecast: Cell Giants To Defend Wireless Tech In EDTX
U.S. District Judge Rodney Gilstrap is scheduled to kick off two new patent infringement trials the first week of June, including one inventor's wireless technology claims against AT&T, T-Mobile, Sprint and Verizon. Here is a look at those cases plus other major intellectual property matters on deck in the coming week.
-
March 31, 2021
Illumina Antitrust Case Iced While Patents Challenged
A California federal judge has delayed a competitor's antitrust suit against Illumina until the DNA-sequencing company's patent infringement claims against the same rival are resolved.
-
February 28, 2020
Illumina Sues Chinese Rival, Again, For 'Brazen Infringement'
Illumina has asked a California federal court to stop Complete Genomics' "latest attempt at brazen infringement" of its DNA sequencing patents as part of a decadelong patent war.